Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
26.2M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$341M
-
Value change
-
+$17.6M
-
Put/Call ratio
-
0.56
-
Number of buys
-
44
-
Number of sells
-
-41
-
Price
-
$13.03
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q4 2021
122 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q4 2021.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.43M shares), BlackRock Inc. (2.46M shares), FRANKLIN RESOURCES INC (2.08M shares), RTW INVESTMENTS, LP (1.91M shares), Logos Global Management LP (1.63M shares), VANGUARD GROUP INC (1.54M shares), PATHSTONE FAMILY OFFICE, LLC (1.44M shares), WASATCH ADVISORS INC (1.24M shares), VR Adviser, LLC (1M shares), and BAKER BROS. ADVISORS LP (806K shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.